Loncar Cancer Immunotherapy Index Announces Merger Replacements – Business Wire (press release)
|
Loncar Cancer Immunotherapy Index Announces Merger Replacements
Business Wire (press release) LENEXA, Kan.–(BUSINESS WIRE)–Loncar Investments, LLC today announced two new additions to the Loncar Cancer Immunotherapy Index, a group of the top 30 companies developing cancer immunotherapy treatments and discovering new ways to use … |
